NCT04814706

Brief Summary

In the past, some guidelines advised no oral intake for at least 8 hours before any surgery, However, research has shown risks associated with excessive fasting, such as postoperative insulin resistance, and advantages in shorter fasting protocols, such as reduced postoperative nausea and vomiting. The perioperative fasting guidelines of the European Society of Anaesthesiology focus on preoperative carbohydrates. They hold that it is safe for patients to drink carbohydrate-rich fluids up to 2 hours before elective surgery and that drinking carbohydrate-rich fluids improves subjective well-being, reduces thirst and hunger, and reduces postoperative insulin resistance at an evidence level of 1++. Nevertheless, data on drinking carbohydrate fluids before surgery in elderly patients are limited. Some factors have been known to influence the gastric emptying rate, as for example, old age, pain, and the use of opioid analgesics. In the previous study, evidence of increased pain was reported in patients undergoing staged bilateral total knee arthroplasty, in whom the second operated knee had greater sensitivity (tertiary hyperalgesia) due to the surgical injury to the first operated knee. In the present study, the investigators will evaluate the effect of old age, surgical stress, pain, and the use of analgesics on the residual gastric volume in elderly patients undergoing staged-bilateral total knee arthroplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 24, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

March 30, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

July 5, 2022

Status Verified

July 1, 2022

Enrollment Period

1.2 years

First QC Date

March 22, 2021

Last Update Submit

July 1, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Gastric volume 1

    Gastric volume measured before induction of spinal anesthesia using ultrasound

    First stage operation, during the gastric volume measuring at preoperative holding area/ an average of 30 minutes

  • Gastric volume 2

    Gastric volume measured before induction of spinal anesthesia using ultrasound

    Second stage operative, during the gastric volume measuring at preoperative holding area/ an average of 30 minutes

Study Arms (1)

Group C

Patients drank carbohydrate fluid 2 hours prior to surgery.

Dietary Supplement: Carbohydrate drinking

Interventions

Carbohydrate drinkingDIETARY_SUPPLEMENT

Administration of carbohydrate fluid

Group C

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants will be patients whom are scheduled to undergo staged bilateral total knee arthroplasty requiring administration of carbohydrate-containing fluid 2 hours prior to surgery.

You may qualify if:

  • Patients scheduled for staged bilateral total knee arthroplasty aged 65 to 85 years
  • American Society of Anesthesiologists physical status classification 1, 2, and 3
  • Body mass index \< 35 kg/cm2
  • Patients administered carbohydrate-containing fluid 2 hours prior to surgery

You may not qualify if:

  • Previous surgery of the upper gastrointestinal tract
  • Achalasia
  • Diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 22, 2021

First Posted

March 24, 2021

Study Start

March 30, 2021

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

July 5, 2022

Record last verified: 2022-07

Locations